Germany-based pharmaceutical giant Bayer
has finally sealed the deal with Monsanto, purchasing the seed giant for $66
billion following months of negotiations and various offers.

The merger is reported to be one of the biggest of all-cash
deal on record.

There
are many effects of this huge merger but as usual, the consumer loses out.
Firstly, it strengthens the monopolization of the world's food supply. It also
means more GMOs and chemicals to be sprayed on them.

Some
are now predicting the merge could also mean the takeover of the marijuana
industry.

According to Big Buds Mag:

“Monsanto has an intimate business relationship with Scotts
Miracle-Gro, a convicted corporate criminal– and Scott's Miracle-Gro is trying
to take over the marijuana industry,”

Is Monsanto Going After the Pot Industry?

In
states where the plant has been legalized or decriminalized, Scott's
Miracle-Gro has looked to capitalize on the ever expanding cannabis industry.

CEO
of SMG, Jim Hagadorn, stated his intentions - spend up to $500 million to
completely buy out the marijuana industry.

A Scott's Miracle-Gro front group has already purchased
General Hydroponics, Botanicare and Gavita:

Of course, Bayer play a leading role in this pre-planned
monopolization.

The
German chemical lords do business with GW Pharmaceuticals, a company based in
the United Kingdom that grows cannabis and produces medicines from its
compounds.

Monsanto and Bayer Share Information on How to Genetically
Engineer Cannabis

Bayer
sells some of GW Pharmaceuticals' products, including Sativex, a costly medical
cannabis spray that's reported to work less effectively than naturally grown
pot.

Both
Monsanto and Bayer have a history of producing chemical weapons used in war and
toxic products, including PCBs, DDT, Agent Orange, Roundup and GMOs.

Members
of the cannabis industry have seen the writing on the wall in terms of the
world's seed monopolies' interest in marijuana.

"Michael
Straumietis, founder and owner of hydroponics nutrients company Advanced
Nutrients, has constantly warned the marijuana community about Monsanto, Scotts
Miracle-Gro, GMO marijuana, and corporate takeover of the marijuana
industry."

The
two corporations, which have now merged into one, have agreed to share trade secrets
about plans to produce genetically modified marijuana.

Monsanto investor George Soros attempts to legalize pot in
Uruguay

"Bayer
is partnered with GW Pharmaceuticals, which grows its own proprietary marijuana
genetics. You can bet Monsanto and Bayer are interested in creating GMO
marijuana," said Straumietis.

Billionaire
investor, George Soros, previously waged a campaign to legalize pot in Uruguay
so that he could invest in the plant. Soros owns 500,000 shares of Monsanto
stock.

"Straumietis
says South American governmental insiders report that Monsanto is working there
on genetically-modified cannabis, along with pharmaceuticalizing THC, other
cannabinoids, and terpenoids."